Plain-English translation of NCT06002581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson's Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing repetitive transcranial magnetic stimulation (rTMS)—a painless, non-invasive procedure that uses magnetic pulses to stimulate the brain—to see if it can improve deep sleep and slow the progression of Parkinson's disease. Researchers believe that deep sleep plays an important role in protecting brain cells from degeneration, and that rTMS might help patients achieve better deep sleep. The trial will compare people who receive the treatment right away with people who receive it after a delay, to see whether the treatment truly makes a difference.
Currently, no medication has been proven to slow down Parkinson's disease progression, only to manage symptoms. This study is exploring a completely new approach: by improving sleep quality through brain stimulation, researchers hope to find a way to actually slow the neurodegenerative process itself.
You likely qualify if…
You likely don't qualify if…
Participants will attend sessions where they receive magnetic brain stimulation—a procedure where a magnetic coil is placed against the scalp; you'll be awake and alert during this painless treatment. The study is divided into two stages: one group receives real stimulation immediately, while the other receives sham (fake) stimulation first, then switches to real treatment later. Throughout the study, you'll have sleep recordings, symptom assessments, and brain imaging to measure whether the treatment is improving your sleep and slowing your Parkinson's symptoms.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China